Copyright
©The Author(s) 2019.
World J Clin Cases. Dec 26, 2019; 7(24): 4277-4284
Published online Dec 26, 2019. doi: 10.12998/wjcc.v7.i24.4277
Published online Dec 26, 2019. doi: 10.12998/wjcc.v7.i24.4277
Table 1 Laboratory data of Patient 1 upon admission
| Parameter | Recorded value | Standard value |
| White blood cell count | 6400 /µL | 3590-9640 /µL |
| Neutrophils | 90.2% | 41.2%-74.7% |
| Lymphocytes | 8.4% | 21.2%-51.0% |
| Hemoglobin | 16.1 g/dL | 13.2-17.2 g/dL |
| Hematocrit | 47.3% | 40.4%-51.1% |
| Platelets | 3.4 × 104 /µL | (14.8-33.9) × 104 /µL |
| C-reactive protein | 18.2 mg/dL | ≤ 0.30 mg/dL |
| Total protein | 5.5 g/dL | 6.7-8.3 g/dL |
| Albumin | 2.9 g/dL | 3.9-4.9 g/dL |
| Aspartate aminotransferase | 232 U/L | 13-33 U/L |
| Alanine aminotransferase | 154 U/L | 6-30 U/L |
| Lactate dehydrogenase | 700 U/L | 119-229 U/L |
| Creatine phosphokinase | 356 U/L | 62-287 U/L |
| Blood nitrogen urea | 35 mg/dL | 8-22 mg/dL |
| Creatinine | 4.72 mg/dL | 0.60-1.10 mg/dL |
| Sodium | 136 mEq/L | 138-146 mEq/L |
| Potassium | 4.4 mEq/L | 3.6-4.9 mEq/L |
| Glucose | 118 mg/dL | 60-160 mg/dL |
| Hemoglobin A1c | 6.7% | 4.6%-6.2% |
| Prothrombin time | 24.8 s | 9.4-12.5 s |
| Activated partial thromboplastin time | 97.8 s | 25.1-36.5 s |
| Fibrinogen | 131 mg/dL | 155-415 mg/dL |
| Fibrin/Fibrinogen degradation products | 68.6 µg/mL | 0-4.9 µg/mL |
Table 2 Laboratory data of Patient 2 upon admission
| Parameter | Recorded value | Standard value |
| White blood cell count | 2260 /µL | 3040-8540 /µL |
| Neutrophils | 61.1% | 38.3%-71.1% |
| Lymphocytes | 37.5% | 21.3%-50.2% |
| Hemoglobin | 10.9 g/dL | 10.8-14.9 g/dL |
| Hematocrit | 32.8% | 35.6%-45.4% |
| Platelets | 15.6 × 104/µL | (15.0-36.1) × 104/µL |
| C-reactive protein | 0.34 mg/dL | ≤ 0.30 mg/dL |
| Total protein | 6.5 g/dL | 6.7-8.3 g/dL |
| Albumin | 3.9 g/dL | 3.9-4.9 g/dL |
| Aspartate aminotransferase | 23 U/L | 13-33 U/L |
| Alanine aminotransferase | 11 U/L | 6-27 U/L |
| Lactate dehydrogenase | 276 U/L | 119-229 U/L |
| Creatine phosphokinase | 200 U/L | 45-163 U/L |
| Blood nitrogen urea | 20 mg/dL | 8-22 mg/dL |
| Creatinine | 1.32 mg/dL | 0.40-0.70 mg/dL |
| Sodium | 144 mEq/L | 138-146 mEq/L |
| Potassium | 3.4 mEq/L | 3.6-4.9 mEq/L |
| Glucose | 191 mg/dL | 60-160 mg/dL |
| Hemoglobin A1c | 6.8% | 4.6%-6.2% |
| Prothrombin time | 12.8 s | 9.4-12.5 s |
| Activated partial thromboplastin time | 22.1 s | 25.1-36.5 s |
| Fibrinogen | 131 mg/dL | 155-415 mg/dL |
| Fibrin/Fibrinogen degradation products | 24.6 µg/mL | 0-4.9µg/mL |
Table 3 Results of antibiotic sensitivity testing (g/mL)
| Strain | PCG | ABPC | CTRX | CFPM | CCL | MEPM | CAM | AZM | CLDM | VCM | LVFX |
| Patient 1 | ≤ 0.06 | ≤ 0.12 | ≤ 0.06 | ≤ 0.06 | ≤ 0.5 | ≤ 0.015 | 1 | > 4 | 0.12 | 0.25 | 1 |
| Patient 2 | ≤ 0.06 | ≤ 0.12 | ≤ 0.06 | ≤ 0.06 | ≤ 0.5 | ≤ 0.015 | 1 | > 4 | 0.5 | 0.25 | 1 |
- Citation: Shibata J, Hiramatsu K, Kenzaka T, Kato T. Pneumococcal infection transmission between family members with congenital asplenia: A case report. World J Clin Cases 2019; 7(24): 4277-4284
- URL: https://www.wjgnet.com/2307-8960/full/v7/i24/4277.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i24.4277
